Sergey Kutsev supported the restoration of industrial pharmacies in Russia at SPIEF 2022
In many European countries, for example, in the Netherlands, industrial pharmacies are successfully operating. In the Soviet years, local pharmacies had prescription departments where drugs were created in the dosage required by a particular patient.
Sergey Kutsev, Director of the Research Centre for Medical Genetics, chief freelance specialist in medical genetics of the Ministry of Health of the Russian Federation, emphasized at the St. Petersburg International Economic Forum that the revival of industrial pharmacies will solve some of the problems of patients with hereditary metabolic diseases.
- The initiative of the Ministry of Health and the Ministry of Industry and Trade to revive this practice is extremely important today. Industrial pharmacies will be able to create drugs such as sodium benzoate, glycerol phenylbutyrate. This could be a good solution for patients that suffer from a number of hereditary metabolic diseases, - said Sergey Kutsev at the SPIEF.
Sodium benzoate is indicated for the treatment of hereditary disorders of the urea cycle. These are monogenic diseases in which urea formation is impaired due to a lack of enzymes or transport proteins, which leads to acute or chronic primary hyperammonemia. The central nervous system is most sensitive to an excess of ammonium. Patients develop cerebral edema and associated complications: depression of consciousness from drowsiness to coma, convulsions, impaired muscle tone and thermoregulation. Sodium benzoate binds excess ammonium in the blood and ensures its excretion.
In 2010, pharmacies were banned from creating prescription drugs if their finished forms are registered and they are produced industrially. In March 2022, the State Duma adopted in the first reading amendments to the law "On the Circulation of Medicines", which will allow pharmacy organizations to manufacture medicines.